IPO
IPO: Codiak Biosciences Targets Exosomes
Codiak Biosciences is developing exosome-based therapeutics to treat diseases. Exosomes are naturally-occurring extracellular vesicles that carry prot...
DISCOVERIES
Here Is A New Class Of RNA Therapeutics
The approval in 2018 of a new drug to treat polyneuropathy caused by a rare and frequently fatal disease called hereditary transthyretin-mediated amy...
STARTUPS
What Illumina Ventures’ Portfolio Says About The Science And Business Models Of The Future Care Delivery System
A look inside a leading venture capital firm’s portfolio is like a lens for understanding the current state of the future of healthcare. Illumin...
SCIENCE
What Is Cell Squeeze Technology?
Cell Squeeze® is a commercial technology designed to manipulate individual cells through mild perturbation that leaves the cells viable after mechanop...
